Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-25

Clinical Trial Update: Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome

View source ↗

Summary

Georgetown-sponsored trial investigated proteomics of cerebrospinal fluid in Chronic Fatigue Syndrome and related conditions and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Georgetown University | Conditions: Chronic Fatigue Syndrome, Fibromyalgia | Status: COMPLETED